iHaveNet.com
Health - Treatment Options for COPD Are Limited But Can Be Effective | Health
Online Breaking News Headlines Single Source to Headlines Breaking News Current Events Top Stories. Find out what is happening in News & the World. Check out iHaveNet.com for the latest news & current events articles plus Movie Reviews, Wolfgang Puck Recipes, NFL Previews Analysis and Politics. Your Single Source to News Articles, Current Events & Reviews.
  • HOME
  • WORLD
    • Africa
    • Asia Pacific
    • Balkans
    • Caucasas
    • Central Asia
    • Eastern Europe
    • Europe
    • Indian Subcontinent
    • Latin America
    • Middle East
    • North Africa
    • Scandinavia
    • Southeast Asia
    • United Kingdom
    • United States
    • Argentina
    • Australia
    • Austria
    • Benelux
    • Brazil
    • Canada
    • China
    • France
    • Germany
    • Greece
    • Hungary
    • India
    • Indonesia
    • Ireland
    • Israel
    • Italy
    • Japan
    • Korea
    • Mexico
    • New Zealand
    • Pakistan
    • Philippines
    • Poland
    • Russia
    • South Africa
    • Spain
    • Taiwan
    • Turkey
    • United States
  • USA
    • ECONOMICS
    • EDUCATION
    • ENVIRONMENT
    • FOREIGN POLICY
    • POLITICS
    • OPINION
    • TRADE
    • Atlanta
    • Baltimore
    • Bay Area
    • Boston
    • Chicago
    • Cleveland
    • DC Area
    • Dallas
    • Denver
    • Detroit
    • Houston
    • Los Angeles
    • Miami
    • New York
    • Philadelphia
    • Phoenix
    • Pittsburgh
    • Portland
    • San Diego
    • Seattle
    • Silicon Valley
    • Saint Louis
    • Tampa
    • Twin Cities
  • BUSINESS
    • FEATURES
    • eBUSINESS
    • HUMAN RESOURCES
    • MANAGEMENT
    • MARKETING
    • ENTREPRENEUR
    • SMALL BUSINESS
    • STOCK MARKETS
    • Agriculture
    • Airline
    • Auto
    • Beverage
    • Biotech
    • Book
    • Broadcast
    • Cable
    • Chemical
    • Clothing
    • Construction
    • Defense
    • Durable
    • Engineering
    • Electronics
    • Firearms
    • Food
    • Gaming
    • Healthcare
    • Hospitality
    • Leisure
    • Logistics
    • Metals
    • Mining
    • Movie
    • Music
    • Newspaper
    • Nondurable
    • Oil & Gas
    • Packaging
    • Pharmaceutic
    • Plastics
    • Real Estate
    • Retail
    • Shipping
    • Sports
    • Steelmaking
    • Textiles
    • Tobacco
    • Transportation
    • Travel
    • Utilities
  • WEALTH
    • CAREERS
    • INVESTING
    • PERSONAL FINANCE
    • REAL ESTATE
    • MARKETS
    • BUSINESS
  • STOCKS
    • ECONOMY
    • EMERGING MARKETS
    • STOCKS
    • FED WATCH
    • TECH STOCKS
    • BIOTECHS
    • COMMODITIES
    • MUTUAL FUNDS / ETFs
    • MERGERS / ACQUISITIONS
    • IPOs
    • 3M (MMM)
    • AT&T (T)
    • AIG (AIG)
    • Alcoa (AA)
    • Altria (MO)
    • American Express (AXP)
    • Apple (AAPL)
    • Bank of America (BAC)
    • Boeing (BA)
    • Caterpillar (CAT)
    • Chevron (CVX)
    • Cisco (CSCO)
    • Citigroup (C)
    • Coca Cola (KO)
    • Dell (DELL)
    • DuPont (DD)
    • Eastman Kodak (EK)
    • ExxonMobil (XOM)
    • FedEx (FDX)
    • General Electric (GE)
    • General Motors (GM)
    • Google (GOOG)
    • Hewlett-Packard (HPQ)
    • Home Depot (HD)
    • Honeywell (HON)
    • IBM (IBM)
    • Intel (INTC)
    • Int'l Paper (IP)
    • JP Morgan Chase (JPM)
    • J & J (JNJ)
    • McDonalds (MCD)
    • Merck (MRK)
    • Microsoft (MSFT)
    • P & G (PG)
    • United Tech (UTX)
    • Wal-Mart (WMT)
    • Walt Disney (DIS)
  • TECH
    • ADVANCED
    • FEATURES
    • INTERNET
    • INTERNET FEATURES
    • CYBERCULTURE
    • eCOMMERCE
    • mp3
    • SECURITY
    • GAMES
    • HANDHELD
    • SOFTWARE
    • PERSONAL
    • WIRELESS
  • HEALTH
    • AGING
    • ALTERNATIVE
    • AILMENTS
    • DRUGS
    • FITNESS
    • GENETICS
    • CHILDREN'S
    • MEN'S
    • WOMEN'S
  • LIFESTYLE
    • AUTOS
    • HOBBIES
    • EDUCATION
    • FAMILY
    • FASHION
    • FOOD
    • HOME DECOR
    • RELATIONSHIPS
    • PARENTING
    • PETS
    • TRAVEL
    • WOMEN
  • ENTERTAINMENT
    • BOOKS
    • TELEVISION
    • MUSIC
    • THE ARTS
    • MOVIES
    • CULTURE
  • SPORTS
    • BASEBALL
    • BASKETBALL
    • COLLEGES
    • FOOTBALL
    • GOLF
    • HOCKEY
    • OLYMPICS
    • SOCCER
    • TENNIS
  • Subscribe to RSS Feeds EMAIL ALERT Subscriptions from iHaveNet.com RSS
    • RSS | Politics
    • RSS | Recipes
    • RSS | NFL Football
    • RSS | Movie Reviews

Treatment Options for COPD Are Limited But Can Be Effective
Howard LeWine, M.D.

HOME > HEALTH

 

SocialTwist Tell-a-Friend

Q: I have COPD. My doctor tells me that my main problem is chronic bronchitis, but I also have some mild emphysema. I quit smoking 4 years ago. I'm on three different inhalers. I don't seem to be getting any better. I wonder if giving up cigarettes was worth it. What do you think?

A: Most people with chronic obstructive pulmonary disease (COPD) have a combination of chronic bronchitis and emphysema.

And like you, they often share your frustration. But don't go back to smoking. That is the one thing you can do to prevent your COPD from getting worse.

Other than not smoking, treatment options for COPD are limited. And those that do work only help decrease symptoms. They can't reverse the lung damage that's already occurred.

On a more positive note, inhaled medicines can decrease your coughing and shortness of breath. Also they help to reduce how often COPD flare-ups occur. Doctors call these COPD exacerbations.

The inhaled drugs most commonly used are:

--Long-acting beta agonists, such as salmeterol (Serevent) and formoterol. These drugs help keep airways open.

--Anti-cholinergic agents, such as ipratropium (Atrovent) and tiotropium (Spiriva). These drugs also help keep airways open. Some experts believe they are slightly more effective than long-acting beta agonists for COPD.

--Corticosteroids, such fluticasone (Flovent), budesonide and many others. Inhaled corticosteroids decrease inflammation in the airways.

Many people with COPD use an inhaler that combines a long-acting beta agonist to open the airways and a corticosteroid. Two examples are Advair and Symbicort.

There is some controversy about which inhalers are the most effective in reducing symptoms and number of flare-ups of COPD. In this month's issue of the journal Chest, researchers reported results of a study examining the question: "Do people have fewer flare-ups of COPD if they use an inhaled corticosteroid daily?"

The question is important because people with COPD who inhale corticosteroids daily have a higher risk of pneumonia than those who don't use them. The researchers' findings suggest that inhaled corticosteroids for the average person with COPD do not prevent flare-ups.

However, don't stop any of your inhalers without discussing it with your doctor. Since you main problem is chronic bronchitis, you may be getting more benefit than you realize.

Howard LeWine, M.D. is a practicing internist at Brigham and Women's Hospital in Boston and Chief Medical Editor of Internet Publishing at Harvard Health Publications, Harvard Medical School.

 

SocialTwist Tell-a-Friend

 

  • Questions to Ask Your Doctor Before You Fill That Prescription
  • Cleaning Naturally Improves Indoor Air Quality
  • Time for Tooth Whitening? Know Your Options
  • Is it Safe to Take High Doses of Vitamin D
  • Bad Breath and Body Odor, Be Gone
  • Risk of Shingles Increases With Age, But Vaccine is Available
  • Treatment Options for Poor Bladder Function

(c) 2010 Harvard Health Watch, Howard LeWine, M.D.

 

Search Powered By Google

Google Search   

advertisement

Healthcare Jobs

Healthcare Jobs

Medical Jobs

Advertisement

Your Ad Here
Your Ad Here

Advertisement

Advertisement

  • HOME
  • WORLD
  • USA
  • BUSINESS
  • WEALTH
  • STOCKS
  • TECH
  • HEALTH
  • LIFESTYLE
  • ENTERTAINMENT
  • SPORTS

 

Health - Treatment Options for COPD Are Limited But Can Be Effective

  • Services:
  • RSS Feeds
  • Shopping
  • Email Alerts
  • Site Map
  • Privacy